Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies

Gender Medicine

Volumn 9, Issue 1 SUPPL., 2012, Pages

  Pham, Bryan ^a   Rhodes, Helen ^a   Milbourne, Andrea ^a   Adler Storthz, Karen ^b   Follen, Michele ^a,c   Scheurer, Michael E ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS DENTAL BRANCH AT HOUSTON   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cervical dysplasia; epidemiology; optical technologies; risk factors

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CLIMACTERIUM; CLINICAL ASSESSMENT; EDUCATIONAL STATUS; FEMALE; FLUORESCENCE SPECTROSCOPY; GENITAL TRACT INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; REFLECTANCE POINT SPECTROSCOPY; RISK FACTOR; SOCIAL ASPECT; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; FEMALE; HUMANS; LOGISTIC MODELS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; RISK FACTORS; SPECTROMETRY, FLUORESCENCE; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS; YOUNG ADULT;

EID: 84857326358     PISSN: 15508579     EISSN: 18787398     Source Type: Journal    
DOI: 10.1016/j.genm.2011.10.006     Document Type: Article

References (24)

1. D. Parkin, F. Bray, J. Ferlay, P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
2. J.M. Walboomers, M.V. Jacobs, M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19 (Pubitemid 29406813)
3. L. Gustafsson, J. Pontn, M. Zack, H. Adami International incidence rates of invasive cervical cancer after introduction of cytological screening Cancer Causes Control 8 1997 755 763 (Pubitemid 27404646)
4. A. Jemal Cancer Facts & Figures 2007 2007 American Cancer Society Atlanta, Ga
5. R. Insinga, A. Glass, B. Rush The health care costs of cervical human papillomavirus-related disease Am J Obstet Gynecol 191 2004 114 120 (Pubitemid 39077963)
6. M. Brewer, U. Utzinger, E. Silva Fluorescence spectroscopy for in vivo characterization of ovarian tissue Lasers Surg Med 29 2001 128 135 (Pubitemid 32808300)
7. Y.N. Mirabal, S.K. Chang, E.N. Atkinson Reflectance spectroscopy for in vivo detection of cervical precancer J Biomed Opt 7 2002 587 594 (Pubitemid 35459940)
8. F. Bosch, N. Muoz, S. de Sanjos Human papillomavirus and other risk factors for cervical cancer Biomed Pharmacother 51 1997 268 275 (Pubitemid 27296838)
9. Resnick R, Cornelissen M, Wright D, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 2018;82:14771484.
10. D. Hosmer, S. Lemeshow Applied Logistic Regression 1989 Wiley Interscience New York, NY
11. X. Castellsagu, N. Muoz Cofactors in human papillomavirus carcinogenesisrole of parity, oral contraceptives, and tobacco smoking J Natl Cancer Inst Monogr 2003 2003 20 28
12. P. Castle, A. Giuliano Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors J Natl Cancer Inst Monogr 2003 29 34
13. N. Muoz, S. Franceschi, C. Bosetti Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study Lancet 359 2002 1093 1101 (Pubitemid 34270732)
14. L. Brinton, W. Reeves, M. Brenes Oral contraceptive use and risk of invasive cervical cancer Int J Epidemiol 19 1990 4 11 (Pubitemid 20126830)
15. J.R. Daling, M.M. Madeleine, B. McKnight The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection Cancer Epidemiol Biomarkers Prev 5 1996 541 548 (Pubitemid 26235021)
16. L. Kjellberg, G. Hallmans, A. Ahren Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection Br J Cancer 82 2000 1332 1338 (Pubitemid 30145354)
17. V. Moreno, F. Bosch, N. Muoz Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study Lancet 359 2002 1085 1092 (Pubitemid 34270731)
18. E.L. Franco, E. Duarte-Franco, A. Ferenczy Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection CMAJ 164 2001 1017 1025 (Pubitemid 34412231)
19. W.M. Schoell, M.F. Janicek, R. Mirhashemi Epidemiology and biology of cervical cancer Semin Surg Oncol 16 1999 203 211 (Pubitemid 29177578)
20. D. Saslow, C.D. Runowicz, D. Solomon American Cancer Society guideline for the early detection of cervical neoplasia and cancer CA Cancer J Clin 52 2002 342 362 (Pubitemid 35446606)
21. K.N. Gaarenstroom, P. Melkert, J.M. Walboomers Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia Int J Gynecol Cancer 4 1994 73 78 (Pubitemid 24179774)
22. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at a National Cancer Institute Workshop, Bethesda Maryland, U.S.A., December 1213, 1988 J Reprod Med 34 1989 779 785
23. C.Y. Lee, W.K. Ng A follow-up study of atypical squamous cells in gynecologic cytology using conventional Papanicolaou smears and liquid-based preparations: the impact of the Bethesda System 2001 Am J Clin Pathol 127 2007 548 555 (Pubitemid 46587467)
24. A. Malpica, J.P. Matisic, D.V. Niekirk Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues Gynecol Oncol 99 Suppl 1 2005 S38 S52